Myelin Support Complex.

Methylcobalamin is the cofactor for methionine synthase, the enzyme that regenerates methionine and therefore the S-adenosylmethionine used for phospholipid methylation in nerve sheath membranes. Low B12 status stalls that methylation directly.

5-methyltetrahydrofolate is the methyl donor that methionine synthase hands to cobalamin, so folate and B12 only work as a pair in the one-carbon cycle. Supplying one without the other leaves the cycle blocked at the other step.

Betaine donates a methyl group to homocysteine through betaine-homocysteine methyltransferase, a folate-independent route to methionine. It keeps the S-adenosylmethionine pool topped up when the folate route runs slowly.

Citicoline is the rate-limiting intermediate of the Kennedy pathway that builds phosphatidylcholine, a major structural phospholipid of nerve membranes. It supplies membrane material directly rather than acting as a cofactor.

Phosphatidylcholine is a principal phospholipid of the lipid-rich sheath around nerve fibres and is also a substrate for further head group chemistry. It provides the bulk lipid the methylation steps then modify.

Serine condenses with palmitoyl-CoA in the first committed step of sphingolipid formation, and sphingolipids are the defining lipid class of nerve sheath membranes. It is a direct precursor rather than a support nutrient.

Serine palmitoyltransferase, the enzyme that starts sphingolipid formation, requires pyridoxal-5-phosphate as its cofactor. B6 status therefore gates the same step that serine supplies the substrate for.

Docosahexaenoic acid is incorporated into the phospholipids of nerve membranes and sets their fluidity and thickness. It occupies the acyl positions of the same phospholipids that choline and serine build the head groups for.

Biotin is the cofactor for acetyl-CoA carboxylase, the committed step of fatty acid synthesis that supplies the long chain lipids of nerve sheath membranes. It also serves pyruvate carboxylase in the energy supply to those cells.

Sphingomyelin is the major sphingolipid of the nerve sheath and dietary sphingomyelin supplies the ceramide backbone after gut hydrolysis. It arrives as finished lipid rather than as a precursor needing assembly.

Plasmalogens are ether-linked phospholipids that make up a large share of nerve sheath phospholipid and are built in peroxisomes by a route separate from the Kennedy pathway. They cover a lipid class choline donors do not.

Benfotiamine raises intracellular thiamine diphosphate, the cofactor for transketolase and for the dehydrogenase complexes that supply energy to nerve tissue. Its lipid-soluble form reaches those tissues at higher levels than thiamine salts.

Acetyl-L-carnitine carries fatty acids into mitochondria for energy and supplies acetyl groups used in lipid and neurotransmitter synthesis. It is standard in nerve-directed formulas beside the B vitamin and phospholipid arms.

Lipoic acid is the cofactor of the pyruvate and alpha-ketoglutarate dehydrogenase complexes and also regenerates the reduced forms of vitamin C, vitamin E and glutathione. Both roles apply to lipid-rich nerve tissue with a high energy demand.

Choline is incorporated into phosphatidylcholine through the CDP-choline pathway and then into sphingomyelin, both structural lipids of the myelin sheath. Without adequate choline the cell draws on membrane phosphatidylcholine to make acetylcholine and free choline. A myelin-support blend that supplies choline donors is supplying the head group the membrane lipids are built from. This is structural biochemistry rather than a measured combination trial.

Riboflavin becomes FAD, which MTHFR needs to generate 5-methyltetrahydrofolate, the methyl donor that regenerates methionine. Methionine feeds S-adenosylmethionine, the methyl source used in phospholipid and myelin basic protein methylation. A folate and B12 blend without riboflavin leaves one cofactor of that cycle unsupported. The relationship is textbook one-carbon biochemistry.

Thiamine pyrophosphate gates entry of pyruvate into the citric acid cycle and drives transketolase in the pentose phosphate pathway, which supplies NADPH for fatty acid synthesis. Myelin lipid turnover is energetically expensive and depends on both. Benfotiamine already sits in this blend as a lipid-soluble thiamine derivative, so plain thiamine covers the same cofactor role by a different absorption route. Neither displaces the other.

S-adenosylmethionine is made by methionine adenosyltransferase, a magnesium-dependent enzyme, and choline kinase and CTP:phosphocholine cytidylyltransferase both work on magnesium-ATP complexes. A methyl-donor stack without magnesium is short of the metal that the transfer reactions run on. Magnesium is also the counter-ion for intracellular ATP generally. The pairing is cofactor logic, not a combination trial.

Betaine donates a methyl group to homocysteine through betaine homocysteine methyltransferase, which holds zinc at its active site to activate the thiol. This blend already carries betaine, so zinc status determines how well that route runs. Zinc is also structural in many transcription factors governing oligodendrocyte gene expression. Read it as a cofactor pairing rather than a clinical finding.

Fatty acid desaturases that make long-chain unsaturated myelin lipids are iron-dependent, and oligodendrocytes hold high iron stores to sustain that lipid output. Iron status therefore sits upstream of myelin lipid production. An umbrella review of iron supplementation in children reported associations with cognitive development measures, which is an association in a population and not a demonstration that iron acts on myelin. Iron competes with zinc and copper for absorption, so separation of doses is ordinary formulation practice.

Sustained zinc intake induces intestinal metallothionein, which binds copper in the enterocyte and lowers copper absorption. Copper itself is required by cytochrome c oxidase for oxidative energy supply and by ferroxidases that mobilise iron. In a blend that carries zinc for the methyltransferase role, copper is the mineral to keep an eye on. The competition is textbook mineral pharmacology.

Methylcobalamin and 5-methyltetrahydrofolate exist in this blend to regenerate methionine, which is then adenosylated to S-adenosylmethionine. Supplying SAM-e directly enters the cycle downstream of that regeneration. Phosphatidylethanolamine N-methyltransferase uses three SAM molecules to make one phosphatidylcholine, so methyl supply and membrane lipid synthesis are the same budget. Adding both a donor and its precursors is a supply question, not an additive effect claim.

Methionine synthase transfers a methyl group from 5-methyltetrahydrofolate via methylcobalamin to homocysteine, producing methionine. Dietary methionine and the salvage route both feed the same pool. Adding methionine to a folate and B12 stack changes which side of that cycle is rate limiting. High methionine intake also raises homocysteine transiently, which is why the methyl donors matter alongside it.

Myelin is lipid-dense and turns over slowly, which makes its membranes dependent on the cell's ability to keep peroxidation in check. Glutathione peroxidase reduces lipid hydroperoxides using glutathione as the electron source, and dihydrolipoic acid can regenerate glutathione from its oxidised form. The pairing is a recycling relationship between two thiol pools. It describes redox chemistry, not a clinical outcome.

Glutathione synthesis is limited by cysteine availability, and NAC is a deacetylated cysteine source that survives first pass better than free cysteine. Cysteine itself comes from homocysteine through the transsulfuration pathway, which is B6 dependent, and this blend already carries P5P. So NAC and the methyl donors meet at the same crossroads in homocysteine handling. The relationship is settled pathway biochemistry.

EPA and DHA share elongation and desaturation steps and compete with arachidonic acid for position in membrane phospholipids. DHA dominates in neural membranes while EPA is the more active substrate for the resolvin series. A blend supplying DHA alone leaves the EPA-derived mediators unsupplied. The two are usually formulated together for that reason.

In krill oil a meaningful share of EPA and DHA is esterified to phosphatidylcholine rather than to a triglyceride backbone. That means the same capsule contributes both the fatty acid and the choline-bearing head group. For a blend built around membrane phospholipid supply the two arrive together. Neither delivery form is presented here as preferable; they differ in carrier chemistry.

Long-chain polyunsaturated fats such as DHA are the most oxidisable membrane lipids, and alpha-tocopherol terminates the peroxidation chain reaction inside the bilayer. Vitamin C and thiol pools then regenerate the tocopheroxyl radical back to tocopherol. Raising polyunsaturated intake without the lipid-phase antioxidant leaves that chemistry one-sided. This is standard formulation practice with omega-3 blends.

Alpha-tocopherol is consumed when it stops a lipid peroxidation chain, and ascorbate donates an electron to return it to the active form. That handoff happens at the membrane surface where the two phases meet. In a lipid-heavy blend the water-soluble partner is what keeps the lipid-soluble one in circulation. The recycling couple is textbook redox chemistry.

Taurine derives from cysteine through the same transsulfuration branch that NAC and homocysteine feed. It also conjugates bile acids, which matters for absorbing the lipid-soluble components of a blend like this. In nervous tissue it acts as an osmolyte and membrane stabiliser. The connection is metabolic and structural rather than an outcome finding.

Carnitine palmitoyltransferase needs free carnitine to move long-chain acyl groups across the inner mitochondrial membrane. Acetyl-L-carnitine donates its acetyl group and leaves free carnitine behind, so the two forms interconvert. Carnitine biosynthesis itself is ascorbate-dependent, tying it to the vitamin C row above. Read it as shuttle chemistry, not an added effect.

Calcitriol binds a nuclear receptor that alters transcription in many cell types including oligodendrocyte precursors. That is receptor biology described in cell and animal work rather than a demonstrated human effect on myelin. Vitamin D is also fat soluble, so it is absorbed alongside the lipid components of this kind of blend. Confidence sits at the mechanistic level.

Lecithin acts both as a dietary phospholipid source and as an emulsifier that disperses lipid-soluble actives in the gut. In a blend already carrying phosphatidylcholine and plasmalogens, lecithin broadens the phospholipid class mix. It also carries phosphatidylinositol, a distinct signalling lipid. The role is formulation and substrate at once.

Two distinct B12 cofactor forms do two different jobs, and only one is methylcobalamin. Adenosylcobalamin converts methylmalonyl-CoA to succinyl-CoA, and when that step lags, methylmalonyl-CoA accumulates and odd-chain fatty acids are incorporated into membrane lipid. A blend that supplies only the methyl form covers one arm of B12 biochemistry. Total cobalamin status is what determines both.

Beyond methylation, tetrahydrofolate derivatives supply one-carbon units for purine and thymidylate synthesis, which oligodendrocyte proliferation depends on. A systematic review has examined folate supplementation in adults with nerve sensation complaints and reported improvements in the included trials, with the authors noting small sample sizes and heterogeneity. A second systematic review describes folate exchange with the gut microbiome, which affects how much reaches the host. Both are context for the cofactor role rather than proof of a myelin effect.

A 2026 systematic review of folate and the human enteric microbiome describes bacterial species that synthesise folate and others that compete for it, with net host effect depending on community composition. That places the microbiome upstream of the folate this blend supplies. The review reports biological mechanisms and clinical implications rather than a tested probiotic-plus-folate outcome. Read it as a modulating relationship with real but indirect grounding.